treatment for schizophrenia patients: double-blind randomized controlled trial study

Not Applicable

• Conditions: Schizophrenia.; Schizophrenia

• Registration Number: IRCT20210608051514N2
• Lead Sponsor: Zanjan University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 1 November 2021

Recruitment & Eligibility

• Status: Pending
• Sex: All
• Target Recruitment: 40

Inclusion Criteria

1- Having the ability of informed consent to participate in research
2_Have a minimum age of 18 and a maximum of 65 years
3_have a diagnosis of schizophrenia or schizoaffective disorder
4_ The same dose and drug used before the start and during the research
5_ Being right-handed
6_ Stabilization in drug treatment for at least 7 weeks

Exclusion Criteria

1_Have a history of suicide and abuse of alcohol and substances other than caffeine and tobacco
2_Have a history of neurological diseases
3_Have a disease related to the scalp
4_Have a history of head trauma
5_ Existence of device or tool in the head
6- Leaving the research after being absent in two consecutive sessions
7- Pregnancy or breastfeeding

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
egative symptoms:Theoretical definition: It is one of the clinical symptoms in schizophrenia that includes superficial emotion, poor speech, lack of motivation, unhappiness and social transgression.Operational definition: The score that a person gets from the positive and negative symptoms of schizophrenia.Positive symptoms: Theoretical definition includes delusions, delusions, disturbed speech, and disturbed behavior that persist throughout a one-month period.Operational definition: The score that a person gets from the positive and negative symptoms of schizophrenia. Timepoint: Pre-test-post-test-one-month follow-up-3 moth follow-up. Method of measurement: The score that a person gets from the questionnaire for measuring positive and negative symptoms in schizophrenia.